Artemii Savin
Papers
1
Total Citations
14
H-Index
1
About
Artemii Savin is a rising innovator in the field of nucleic acid nanotechnology and theranostics, with a focused interest in developing intelligent, RNA-targeting therapeutic agents. His most notable contribution is the design of a bifunctional RNA-targeting deoxyribozyme nanodevice, a groundbreaking DNA-based platform that simultaneously diagnoses and treats disease by reporting the presence of a specific RNA target through a fluorescence increase while cleaving it with high selectivity. This work, published in 2020 and garnering 14 citations, represents a significant step toward integrated, programmable theranostic agents that operate under near-physiological conditions. Savin’s research sits at the intersection of synthetic biology, nanomedicine, and molecular diagnostics, offering a versatile framework for addressing diseases at the RNA level. His achievements highlight a promising trajectory in the development of autonomous, DNA-based nanodevices for precision medicine, making his work highly relevant for students and researchers interested in the next generation of smart therapeutics and biosensors.
Research Focus
Key Achievements
Top Papers
- 1